Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.0100-0.0150 (-0.50%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.58M
Enterprise value 2.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.79
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.10

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-78.50%
S&P500 52-week change 322.64%
52-week high 321.2500
52-week low 32.5100
50-day moving average 36.0150
200-day moving average 37.4991

Share statistics

Avg vol (3-month) 332.05k
Avg vol (10-day) 328.57k
Shares outstanding 52.52M
Implied shares outstanding 62.52M
Float 82.23M
% held by insiders 14.71%
% held by institutions 115.09%
Shares short (15 Apr 2024) 469.73k
Short ratio (15 Apr 2024) 41.23
Short % of float (15 Apr 2024) 42.82%
Short % of shares outstanding (15 Apr 2024) 42.77%
Shares short (prior month 15 Mar 2024) 446.41k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 319 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,695.88%

Management effectiveness

Return on assets (ttm)-75.71%
Return on equity (ttm)-130.94%

Income statement

Revenue (ttm)733.87k
Revenue per share (ttm)0.41
Quarterly revenue growth (yoy)-63.40%
Gross profit (ttm)N/A
EBITDA -21.39M
Net income avi to common (ttm)-21.24M
Diluted EPS (ttm)-11.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.48M
Total cash per share (mrq)2.17
Total debt (mrq)115.25k
Total debt/equity (mrq)1.21%
Current ratio (mrq)3.12
Book value per share (mrq)4.04

Cash flow statement

Operating cash flow (ttm)-16.04M
Levered free cash flow (ttm)-8.75M